Page last updated: 2024-08-24

orbifloxacin and enrofloxacin

orbifloxacin has been researched along with enrofloxacin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gozalbes, R; Pineda-Lucena, A1
Heinen, E1
Abd El-Aty, AM; Kuroha, M; Nakamura, M; Regmi, NL; Shimoda, M1
Abd El-Aty, AM; Kubota, R; Regmi, NL; Shah, SS; Shimoda, M1
Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z1
Choi, MJ; Damte, D; Gebru, E; Kim, YH; Lee, SJ; Park, SC1
Harada, K; Kataoka, Y; Shimizu, T; Takahashi, T1
Asai, T; Harada, K; Usui, M1
Greenbarg, EH; Secrest, SA1
Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F1

Trials

1 trial(s) available for orbifloxacin and enrofloxacin

ArticleYear
Lack of inhibitory effects of several fluoroquinolones on cytochrome P-450 3A activities at clinical dosage in dogs.
    Journal of veterinary pharmacology and therapeutics, 2007, Volume: 30, Issue:1

    Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dogs; Enrofloxacin; Fluoroquinolones; Injections, Intravenous; Male; Microsomes, Liver; Ofloxacin; Quinidine

2007

Other Studies

9 other study(ies) available for orbifloxacin and enrofloxacin

ArticleYear
QSAR-based solubility model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19

    Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water

2010
Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration.
    Journal of veterinary pharmacology and therapeutics, 2002, Volume: 25, Issue:1

    Topics: Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Dogs; Enrofloxacin; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Quinolones

2002
Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
    Journal of veterinary pharmacology and therapeutics, 2005, Volume: 28, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytochrome P-450 CYP1A1; Dogs; Drug Interactions; Enrofloxacin; Fluoroquinolones; Male; Microsomes, Liver; Norfloxacin; Ofloxacin

2005
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
    Se pu = Chinese journal of chromatography, 2007, Volume: 25, Issue:4

    Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization

2007
Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
    Veterinary microbiology, 2012, Jan-27, Volume: 154, Issue:3-4

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Base Sequence; Ciprofloxacin; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation

2012
Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs.
    Acta veterinaria Scandinavica, 2012, Mar-20, Volume: 54

    Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dogs; Enrofloxacin; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2012
Application of enrofloxacin and orbifloxacin disks approved in Japan for susceptibility testing of representative veterinary respiratory pathogens.
    The Journal of veterinary medical science, 2014, Volume: 76, Issue:10

    Topics: Actinobacillus pleuropneumoniae; Anti-Bacterial Agents; Bacteriological Techniques; Ciprofloxacin; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Japan; Mannheimia haemolytica; Pasteurella multocida

2014
What Is Your Diagnosis? Fungal pneumonia and aspergillosis.
    Journal of the American Veterinary Medical Association, 2016, May-01, Volume: 248, Issue:9

    Topics: Air Sacs; Animals; Anti-Infective Agents; Aspergillosis; Bird Diseases; Ciprofloxacin; Diagnosis, Differential; Eagles; Enrofloxacin; Female; Fluid Therapy; Fluoroquinolones; Iron-Dextran Complex; Radiography, Thoracic; Respiratory Tract Infections; Vitamin B Complex

2016
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
    BMC veterinary research, 2017, Apr-28, Volume: 13, Issue:1

    Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin

2017